Effects of guanylyl cyclase and protein kinase G inhibitors on vasodilatation in non-tolerant and tolerant bovine coronary arteries

被引:5
作者
De la Lande, IS [1 ]
Stafford, I [1 ]
Horowitz, JD [1 ]
机构
[1] Univ Adelaide, NW Adelaide Hlth Serv, Cardiol Unit, Woodville, SA 5011, Australia
基金
英国医学研究理事会;
关键词
coronary artery; bovine; guanylyl cyclase soluble; protein kinase G; glyceryl trinitrate; S-nitroso-N-acetylpenicillamine; tolerance;
D O I
10.1016/S0014-2999(99)00092-8
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects in bovine coronary arteries of the soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) were examined in order to establish the relative importance of the enzyme (a) in the vasodilator actions of glyceryl trinitrate and S-nitroso-N-acetylpenicillamine and (b) in induction of tolerance to these agents. ODQ strongly inhibited responses to both relaxants with IC50's of the order of 0.5 mu M; in contrast, the protein kinase G inhibitor, 8-bromoguanosine-3',5'-monophosphorothioate (Rp-8-Br-cGMPS) had little effect on the responses. Tolerance after pre-incubation with glyceryl trinitrate (10 mu M) was unaffected by co-pre-incubation with ODQ (1.0 mu M), but similar experiments with S-nitroso-N-acetylpenicillamine were inconclusive because tolerance was associated with depressed contractile activity. It is concluded that in bovine coronary arteries soluble guanylyl cyclase is essential for vasorelaxation to both glyceryl trinitrate and S-nitroso-N-acetylpenicillamine but is unimportant for induction of tolerance to glyceryl trinitrate. Our results add weight to the hypothesis of impaired biotransformation rather than guanylyl cyclase desensitisation as the mechanism of in vitro nitrate tolerance. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:39 / 46
页数:8
相关论文
共 28 条
[1]   NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE [J].
BOLOTINA, VM ;
NAJIBI, S ;
PALACINO, JJ ;
PAGANO, PJ ;
COHEN, RA .
NATURE, 1994, 368 (6474) :850-853
[2]  
BRIEN JF, 1986, J PHARMACOL EXP THER, V237, P608
[3]  
BROOKS A, 1995, P AUST SOC CLIN EXP, V2, P41
[4]  
Brunner F, 1996, J PHARMACOL EXP THER, V277, P48
[5]   INHIBITION OF CGMP-DEPENDENT PROTEIN-KINASE BY (RP)-GUANOSINE 3',5'-MONOPHOSPHOROTHIOATES [J].
BUTT, E ;
VANBEMMELEN, M ;
FISCHER, L ;
WALTER, U ;
JASTORFF, B .
FEBS LETTERS, 1990, 263 (01) :47-50
[6]   Heterogeneity of glyceryl trinitrate response in isolated bovine coronary arteries [J].
DelaLande, IS ;
Stafford, I ;
Horowitz, JD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 318 (01) :65-71
[7]   Lack of inhibition of glyceryl trinitrate by diphenyleneiodonium in bovine coronary artery [J].
DelaLande, IS ;
Philp, T ;
Stafford, I ;
Horowitz, JD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 314 (03) :347-350
[8]  
GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184
[9]   S-NITROSOTHIOLS AS VASODILATORS - IMPLICATIONS REGARDING TOLERANCE TO NITRIC OXIDE-CONTAINING VASODILATORS [J].
HENRY, PJ ;
DRUMMER, OH ;
HOROWITZ, JD .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (03) :757-766
[10]  
HENRY PJ, 1989, J PHARMACOL EXP THER, V248, P762